questionsmedicales.fr
Acides nucléiques, nucléotides et nucléosides
Nucléosides
Ribonucléosides
Ribonucléosides : Questions médicales fréquentes
Diagnostic
5
Carence en ribonucléosides
Tests sanguins
Tests biochimiques
Métabolites
Analyse urinaire
Ribonucléosides
Fatigue
Troubles immunitaires
Tests génétiques
Mutations
Symptômes
5
Carence en ribonucléosides
Fatigue
Surconsommation
Troubles gastro-intestinaux
Troubles de l'humeur
Anxiété
Système immunitaire
Infections
Prévention
5
Prévention
Alimentation équilibrée
Surveillance
Complications
Traitements
5
Chimiothérapie
Agents chimiothérapeutiques
Antiviraux
Médicaments anticancéreux
Administration intraveineuse
Ribonucléosides
Effets secondaires
Nausées
Complications
5
Complications
Troubles immunitaires
Effets indésirables
Réactions allergiques
Métabolisme
Croissance cellulaire
Interactions médicamenteuses
Efficacité
Surconsommation
Troubles métaboliques
Facteurs de risque
5
Facteurs de risque
Maladies chroniques
Maladies métaboliques
Production
Habitudes alimentaires
Carence
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ribonucléosides : Questions médicales les plus fréquentes",
"headline": "Ribonucléosides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ribonucléosides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-02",
"dateModified": "2026-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ribonucléosides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Nucléosides",
"url": "https://questionsmedicales.fr/mesh/D009705",
"about": {
"@type": "MedicalCondition",
"name": "Nucléosides",
"code": {
"@type": "MedicalCode",
"code": "D009705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénosine",
"alternateName": "Adenosine",
"url": "https://questionsmedicales.fr/mesh/D000241",
"about": {
"@type": "MedicalCondition",
"name": "Adénosine",
"code": {
"@type": "MedicalCode",
"code": "D000241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénosine-5'-(N-éthylcarboxamide)",
"alternateName": "Adenosine-5'-(N-ethylcarboxamide)",
"url": "https://questionsmedicales.fr/mesh/D019830",
"about": {
"@type": "MedicalCondition",
"name": "Adénosine-5'-(N-éthylcarboxamide)",
"code": {
"@type": "MedicalCode",
"code": "D019830",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "S-(5'-Désoxy-adénosyl)homocystéine",
"alternateName": "S-Adenosylhomocysteine",
"url": "https://questionsmedicales.fr/mesh/D012435",
"about": {
"@type": "MedicalCondition",
"name": "S-(5'-Désoxy-adénosyl)homocystéine",
"code": {
"@type": "MedicalCode",
"code": "D012435",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.262"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adémétionine",
"alternateName": "S-Adenosylmethionine",
"url": "https://questionsmedicales.fr/mesh/D012436",
"about": {
"@type": "MedicalCondition",
"name": "Adémétionine",
"code": {
"@type": "MedicalCode",
"code": "D012436",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.264"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chloro-2 adénosine",
"alternateName": "2-Chloroadenosine",
"url": "https://questionsmedicales.fr/mesh/D015762",
"about": {
"@type": "MedicalCondition",
"name": "Chloro-2 adénosine",
"code": {
"@type": "MedicalCode",
"code": "D015762",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chloro-2 désoxyadénosine",
"alternateName": "Cladribine",
"url": "https://questionsmedicales.fr/mesh/D017338",
"about": {
"@type": "MedicalCondition",
"name": "Chloro-2 désoxyadénosine",
"code": {
"@type": "MedicalCode",
"code": "D017338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.300.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chloro-2 désoxyadénosine",
"alternateName": "Cladribine",
"url": "https://questionsmedicales.fr/mesh/D017338",
"about": {
"@type": "MedicalCondition",
"name": "Chloro-2 désoxyadénosine",
"code": {
"@type": "MedicalCode",
"code": "D017338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.300.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Isopentényladénosine",
"alternateName": "Isopentenyladenosine",
"url": "https://questionsmedicales.fr/mesh/D007541",
"about": {
"@type": "MedicalCondition",
"name": "Isopentényladénosine",
"code": {
"@type": "MedicalCode",
"code": "D007541",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phénylisopropyladénosine",
"alternateName": "Phenylisopropyladenosine",
"url": "https://questionsmedicales.fr/mesh/D010660",
"about": {
"@type": "MedicalCondition",
"name": "Phénylisopropyladénosine",
"code": {
"@type": "MedicalCode",
"code": "D010660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.630"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ticagrélor",
"alternateName": "Ticagrelor",
"url": "https://questionsmedicales.fr/mesh/D000077486",
"about": {
"@type": "MedicalCondition",
"name": "Ticagrélor",
"code": {
"@type": "MedicalCode",
"code": "D000077486",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.096.815"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cytidine",
"alternateName": "Cytidine",
"url": "https://questionsmedicales.fr/mesh/D003562",
"about": {
"@type": "MedicalCondition",
"name": "Cytidine",
"code": {
"@type": "MedicalCode",
"code": "D003562",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.286"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Azacitidine",
"alternateName": "Azacitidine",
"url": "https://questionsmedicales.fr/mesh/D001374",
"about": {
"@type": "MedicalCondition",
"name": "Azacitidine",
"code": {
"@type": "MedicalCode",
"code": "D001374",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.286.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Décitabine",
"alternateName": "Decitabine",
"url": "https://questionsmedicales.fr/mesh/D000077209",
"about": {
"@type": "MedicalCondition",
"name": "Décitabine",
"code": {
"@type": "MedicalCode",
"code": "D000077209",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.286.300.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Décitabine",
"alternateName": "Decitabine",
"url": "https://questionsmedicales.fr/mesh/D000077209",
"about": {
"@type": "MedicalCondition",
"name": "Décitabine",
"code": {
"@type": "MedicalCode",
"code": "D000077209",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.286.300.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Dichlororibofuranosylbenzimidazole",
"alternateName": "Dichlororibofuranosylbenzimidazole",
"url": "https://questionsmedicales.fr/mesh/D004004",
"about": {
"@type": "MedicalCondition",
"name": "Dichlororibofuranosylbenzimidazole",
"code": {
"@type": "MedicalCode",
"code": "D004004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Formycines",
"alternateName": "Formycins",
"url": "https://questionsmedicales.fr/mesh/D005573",
"about": {
"@type": "MedicalCondition",
"name": "Formycines",
"code": {
"@type": "MedicalCode",
"code": "D005573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.410"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Coformycine",
"alternateName": "Coformycin",
"url": "https://questionsmedicales.fr/mesh/D003070",
"about": {
"@type": "MedicalCondition",
"name": "Coformycine",
"code": {
"@type": "MedicalCode",
"code": "D003070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.410.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Guanosine",
"alternateName": "Guanosine",
"url": "https://questionsmedicales.fr/mesh/D006151",
"about": {
"@type": "MedicalCondition",
"name": "Guanosine",
"code": {
"@type": "MedicalCode",
"code": "D006151",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.453"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nucléoside Q",
"alternateName": "Nucleoside Q",
"url": "https://questionsmedicales.fr/mesh/D009704",
"about": {
"@type": "MedicalCondition",
"name": "Nucléoside Q",
"code": {
"@type": "MedicalCode",
"code": "D009704",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.453.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Inosine",
"alternateName": "Inosine",
"url": "https://questionsmedicales.fr/mesh/D007288",
"about": {
"@type": "MedicalCondition",
"name": "Inosine",
"code": {
"@type": "MedicalCode",
"code": "D007288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.573"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Didéoxyinosine",
"alternateName": "Didanosine",
"url": "https://questionsmedicales.fr/mesh/D016049",
"about": {
"@type": "MedicalCondition",
"name": "Didéoxyinosine",
"code": {
"@type": "MedicalCode",
"code": "D016049",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.573.130"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inosine pranobex",
"alternateName": "Inosine Pranobex",
"url": "https://questionsmedicales.fr/mesh/D007542",
"about": {
"@type": "MedicalCondition",
"name": "Inosine pranobex",
"code": {
"@type": "MedicalCode",
"code": "D007542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.573.450"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ribavirine",
"alternateName": "Ribavirin",
"url": "https://questionsmedicales.fr/mesh/D012254",
"about": {
"@type": "MedicalCondition",
"name": "Ribavirine",
"code": {
"@type": "MedicalCode",
"code": "D012254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Showdomycine",
"alternateName": "Showdomycin",
"url": "https://questionsmedicales.fr/mesh/D012787",
"about": {
"@type": "MedicalCondition",
"name": "Showdomycine",
"code": {
"@type": "MedicalCode",
"code": "D012787",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.810"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Toyocamycine",
"alternateName": "Toyocamycin",
"url": "https://questionsmedicales.fr/mesh/D014127",
"about": {
"@type": "MedicalCondition",
"name": "Toyocamycine",
"code": {
"@type": "MedicalCode",
"code": "D014127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tubercidine",
"alternateName": "Tubercidin",
"url": "https://questionsmedicales.fr/mesh/D014372",
"about": {
"@type": "MedicalCondition",
"name": "Tubercidine",
"code": {
"@type": "MedicalCode",
"code": "D014372",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.850"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uridine",
"alternateName": "Uridine",
"url": "https://questionsmedicales.fr/mesh/D014529",
"about": {
"@type": "MedicalCondition",
"name": "Uridine",
"code": {
"@type": "MedicalCode",
"code": "D014529",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.892"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "6-Azauridine",
"alternateName": "Azauridine",
"url": "https://questionsmedicales.fr/mesh/D001380",
"about": {
"@type": "MedicalCondition",
"name": "6-Azauridine",
"code": {
"@type": "MedicalCode",
"code": "D001380",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.892.176"
}
}
},
{
"@type": "MedicalWebPage",
"name": "3-Déazauridine",
"alternateName": "3-Deazauridine",
"url": "https://questionsmedicales.fr/mesh/D015092",
"about": {
"@type": "MedicalCondition",
"name": "3-Déazauridine",
"code": {
"@type": "MedicalCode",
"code": "D015092",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.892.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pseudouridine",
"alternateName": "Pseudouridine",
"url": "https://questionsmedicales.fr/mesh/D011560",
"about": {
"@type": "MedicalCondition",
"name": "Pseudouridine",
"code": {
"@type": "MedicalCode",
"code": "D011560",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.892.628"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tétrahydrouridine",
"alternateName": "Tetrahydrouridine",
"url": "https://questionsmedicales.fr/mesh/D013767",
"about": {
"@type": "MedicalCondition",
"name": "Tétrahydrouridine",
"code": {
"@type": "MedicalCode",
"code": "D013767",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800.892.800"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ribonucléosides",
"alternateName": "Ribonucleosides",
"code": {
"@type": "MedicalCode",
"code": "D012263",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paulina Mierzejewska",
"url": "https://questionsmedicales.fr/author/Paulina%20Mierzejewska",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Mikhail S Drenichev",
"url": "https://questionsmedicales.fr/author/Mikhail%20S%20Drenichev",
"affiliation": {
"@type": "Organization",
"name": "Engelhardt Institute of Molecular Biology, Moscow 119991, Russia. Electronic address: room517@eimb.ru."
}
},
{
"@type": "Person",
"name": "Franck Amblard",
"url": "https://questionsmedicales.fr/author/Franck%20Amblard",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatics, Emory University, Atlanta, GA, USA."
}
},
{
"@type": "Person",
"name": "Raymond F Schinazi",
"url": "https://questionsmedicales.fr/author/Raymond%20F%20Schinazi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatics, Emory University, Atlanta, GA, USA."
}
},
{
"@type": "Person",
"name": "Radek Pohl",
"url": "https://questionsmedicales.fr/author/Radek%20Pohl",
"affiliation": {
"@type": "Organization",
"name": "Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Ribonucleoside Hydrolases-Structure, Functions, Physiological Role and Practical Uses.",
"datePublished": "2023-09-12",
"url": "https://questionsmedicales.fr/article/37759775",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biom13091375"
}
},
{
"@type": "ScholarlyArticle",
"name": "A practical and scalable synthesis of several base modified 3'-O-methyl ribonucleosides.",
"datePublished": "2023-11-10",
"url": "https://questionsmedicales.fr/article/37992558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.carres.2023.108981"
}
},
{
"@type": "ScholarlyArticle",
"name": "rNMPID: a database for riboNucleoside MonoPhosphates in DNA.",
"datePublished": "2024-05-08",
"url": "https://questionsmedicales.fr/article/38736683",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/bioadv/vbae063"
}
},
{
"@type": "ScholarlyArticle",
"name": "Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma.",
"datePublished": "2024-06-12",
"url": "https://questionsmedicales.fr/article/38920074",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/0115665232286359240611051307"
}
},
{
"@type": "ScholarlyArticle",
"name": "Snapshots of the Reaction Coordinate of a Thermophilic 2'-Deoxyribonucleoside/ribonucleoside Transferase.",
"datePublished": "2024-02-13",
"url": "https://questionsmedicales.fr/article/38449528",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acscatal.3c06260"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009705"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ribonucléosides",
"item": "https://questionsmedicales.fr/mesh/D012263"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ribonucléosides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ribonucléosides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ribonucléosides",
"description": "Comment diagnostiquer une carence en ribonucléosides ?\nQuels tests sont utilisés pour évaluer les ribonucléosides ?\nLes ribonucléosides peuvent-ils être mesurés dans l'urine ?\nQuels symptômes indiquent un déséquilibre en ribonucléosides ?\nLes tests génétiques sont-ils utiles pour les ribonucléosides ?",
"url": "https://questionsmedicales.fr/mesh/D012263#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ribonucléosides",
"description": "Quels sont les symptômes d'une carence en ribonucléosides ?\nComment une surconsommation de ribonucléosides se manifeste-t-elle ?\nLes ribonucléosides affectent-ils l'humeur ?\nQuels signes indiquent une toxicité des ribonucléosides ?\nLes ribonucléosides peuvent-ils affecter le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D012263#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ribonucléosides",
"description": "Comment prévenir une carence en ribonucléosides ?\nLes suppléments de ribonucléosides sont-ils recommandés ?\nQuels aliments sont riches en ribonucléosides ?\nLes habitudes de vie influencent-elles les niveaux de ribonucléosides ?\nFaut-il surveiller les niveaux de ribonucléosides chez les malades ?",
"url": "https://questionsmedicales.fr/mesh/D012263#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ribonucléosides",
"description": "Comment traiter une carence en ribonucléosides ?\nLes ribonucléosides sont-ils utilisés en chimiothérapie ?\nQuels médicaments contiennent des ribonucléosides ?\nLes ribonucléosides peuvent-ils être administrés par voie intraveineuse ?\nY a-t-il des effets secondaires aux traitements par ribonucléosides ?",
"url": "https://questionsmedicales.fr/mesh/D012263#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ribonucléosides",
"description": "Quelles complications peuvent survenir avec une carence en ribonucléosides ?\nLes ribonucléosides peuvent-ils causer des effets indésirables graves ?\nComment les ribonucléosides affectent-ils le métabolisme ?\nLes ribonucléosides peuvent-ils interagir avec d'autres médicaments ?\nQuelles sont les conséquences d'une surconsommation de ribonucléosides ?",
"url": "https://questionsmedicales.fr/mesh/D012263#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ribonucléosides",
"description": "Quels facteurs augmentent le risque de carence en ribonucléosides ?\nLes personnes âgées sont-elles à risque de carence ?\nLe stress peut-il affecter les niveaux de ribonucléosides ?\nLes maladies métaboliques influencent-elles les ribonucléosides ?\nLes habitudes alimentaires influencent-elles les niveaux de ribonucléosides ?",
"url": "https://questionsmedicales.fr/mesh/D012263#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en ribonucléosides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins et l'analyse des niveaux d'ARN."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les ribonucléosides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses de métabolites dans les cellules sont utilisés."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides peuvent-ils être mesurés dans l'urine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analyses urinaires peuvent détecter des niveaux de ribonucléosides."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un déséquilibre en ribonucléosides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles immunitaires et anomalies métaboliques peuvent indiquer un déséquilibre."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les ribonucléosides ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations affectant la synthèse des ribonucléosides."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en ribonucléosides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Comment une surconsommation de ribonucléosides se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des troubles gastro-intestinaux et des déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides affectent-ils l'humeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déséquilibre peut influencer l'humeur et provoquer des troubles de l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une toxicité des ribonucléosides ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de toxicité incluent des nausées, des vomissements et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides peuvent-ils affecter le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déséquilibre peut affaiblir le système immunitaire et augmenter les infections."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en ribonucléosides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en acides nucléiques et en ribonucléosides aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les suppléments de ribonucléosides sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être recommandés en cas de carence ou de besoins accrus, après avis médical."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en ribonucléosides ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les viandes, poissons, œufs et certains légumes sont riches en ribonucléosides."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles les niveaux de ribonucléosides ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress, l'alimentation et l'exercice peuvent influencer les niveaux de ribonucléosides."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les niveaux de ribonucléosides chez les malades ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients sous traitement doivent surveiller leurs niveaux pour éviter les complications."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en ribonucléosides ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de ribonucléosides et une alimentation riche en ARN."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides sont-ils utilisés en chimiothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains ribonucléosides sont utilisés comme agents chimiothérapeutiques."
}
},
{
"@type": "Question",
"name": "Quels médicaments contiennent des ribonucléosides ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux et des médicaments anticancéreux contiennent des ribonucléosides."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides peuvent-ils être administrés par voie intraveineuse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains ribonucléosides peuvent être administrés par voie intraveineuse pour un effet rapide."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements par ribonucléosides ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires peuvent inclure des nausées, des éruptions cutanées et des douleurs."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en ribonucléosides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles immunitaires, des infections fréquentes et des maladies métaboliques."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides peuvent-ils causer des effets indésirables graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets indésirables graves peuvent survenir, notamment des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment les ribonucléosides affectent-ils le métabolisme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle crucial dans le métabolisme cellulaire et peuvent influencer la croissance cellulaire."
}
},
{
"@type": "Question",
"name": "Les ribonucléosides peuvent-ils interagir avec d'autres médicaments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent interagir avec certains médicaments, affectant leur efficacité ou leur sécurité."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une surconsommation de ribonucléosides ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des troubles métaboliques et des effets gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en ribonucléosides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée, des maladies chroniques et le stress augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque de carence ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de carence en raison de l'alimentation."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter les niveaux de ribonucléosides ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la synthèse des ribonucléosides dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques influencent-elles les ribonucléosides ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies métaboliques peuvent affecter la production et l'utilisation des ribonucléosides."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les niveaux de ribonucléosides ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en acides nucléiques peut entraîner une carence en ribonucléosides."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/02/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Engelhardt Institute of Molecular Biology, Moscow 119991, Russia. Electronic address: room517@eimb.ru.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatics, Emory University, Atlanta, GA, USA.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatics, Emory University, Atlanta, GA, USA.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 8, CZ-12843 Prague 2, Czech Republic.
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
a Department of Biochemistry, Medical University of Gdansk , Gdansk , Poland.
Publications dans "Ribonucléosides" :
3 publications dans cette catégorie
Affiliations :
a Department of Biochemistry, Medical University of Gdansk , Gdansk , Poland.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA. ytor@ucsd.edu.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA. ytor@ucsd.edu.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Engelhardt Institute of Molecular Biology, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Engelhardt Institute of Molecular Biology, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov str. 32, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya str. 16/10, Moscow 117997, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Bach Institute of Biochemistry, Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow 119071, Russia.
Department of Chemical Enzymology, Chemistry Faculty, Lomonosov Moscow State University, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Bach Institute of Biochemistry, Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow 119071, Russia.
Department of Chemical Enzymology, Chemistry Faculty, Lomonosov Moscow State University, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Bach Institute of Biochemistry, Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow 119071, Russia.
Department of Chemical Enzymology, Chemistry Faculty, Lomonosov Moscow State University, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
2 publications dans cette catégorie
Affiliations :
Bach Institute of Biochemistry, Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow 119071, Russia.
Department of Chemical Enzymology, Chemistry Faculty, Lomonosov Moscow State University, Moscow 119991, Russia.
Publications dans "Ribonucléosides" :
Ribonucleoside hydrolases are enzymes that catalyze the cleavage of ribonucleosides to nitrogenous bases and ribose. These enzymes are found in many organisms: bacteria, archaea, protozoa, metazoans, ...
An easy and efficient large-scale synthesis of 1, 2,-di-O-acetyl-5-O-benzoyl-3-O-methyl-d-ribofuranose (8) was accomplished from commercial 1,2:5,6-di-O-isopropylidene-α-d-allofuranose in 7-steps and ...
Ribonucleoside monophosphates (rNMPs) are the most abundant non-standard nucleotides embedded in genomic DNA. If the presence of rNMP in DNA cannot be controlled, it can lead to genome instability. Th...
We introduce the rNMPID database, which is the first database revealing rNMP-embedment characteristics, strand bias, and preferred incorporation patterns in the genomic DNA of samples from bacterial t...
rNMPID is freely accessible on the web at https://www.rnmpid.org....
The Ribonucleoside-diphosphate Reductase subunit M2 (RRM2) is known to be overexpressed in various cancers, though its specific functional implications remain unclear. This aims to elucidate the role ...
RRM2 data were sourced from multiple databases to assess its diagnostic and prognostic significance in LUAD. We evaluated the association between RRM2 expression and immune cell infiltration, analyzed...
RRM2 was significantly upregulated in LUAD tissues and cells compared to normal counterparts (p<0.05), with rare genetic alterations noted (approximately 2%). This overexpression clearly distinguished...
Our findings highlight the potential utility of RRM2 expression as a biomarker for diagnosing and predicting prognosis in LUAD, shedding new light on the role of RRM2 in this malignancy....
Nucleosides are ubiquitous to life and are required for the synthesis of DNA, RNA, and other molecules crucial for cell survival. Despite the notoriously difficult organic synthesis of nucleosides, 2'...
Ribonucleoside hydrolase C (RihC, EC 3.2.2.1, 3.2.2.2, 3.2.2.3, 3.2.2.7, 3.2.2.8) belongs to the family of ribonucleoside hydrolases Rih and catalyzes the cleavage of ribonucleosides to nitrogenous ba...
Cytomegalovirus (CMV) infection is arguably the most important infectious complication that negatively affects the outcome of solid organ transplantation. For decades, CMV management after transplanta...
Among the many prebiotic phosphorylation chemistries investigated, diamidophosphate (DAP) has shown promising potential for nucleoside phosphorylation. Herein, we show that DAP's phosphorylation capab...
The building blocks for RNA and DNA are made in the cytosol, meaning mitochondria depend on the import and salvage of ribonucleoside triphosphates (rNTPs) and deoxyribonucleoside triphosphates (dNTPs)...
Cytomegalovirus infection (CMV) can be fatal for organ transplant recipients as shown in this case report. Maribavir is a recently approved drug, which can be used for therapy-refractory CMV infection...